Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Halagon
Active substances:
Halofuginone
Estonian, English, Latin
ATC code: QP51BX01
Dosage form: oral solution
Strength: 0,5mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Indication: In newborn calves: • Prevention of diarrhoea due to diagnosed Cryptosporidium parvum infection, in farms with history of cryptosporidiosis. Administration should start in the first 24 to 48 hours of age. • Reduction of diarrhoea due to diagnosed Cryptosporidium parvum infection. Administration should start within 24 hours after the onset of diarrhoea. In both cases, the reduction of oocysts excretion has been demonstrated.
Safety features: No
Marketing authorization holder: Emdoka 
Marketing authorization number: EU/2/16/201 
Marketing authorization issued on: December 13, 2016 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1734892  Halagon  oral solution  0,5mg 1ml 290ml 1TK  Prescription      22.11.2017     
1734904  Halagon  oral solution  0,5mg 1ml 490ml 1TK  Prescription      22.12.2023     
1734915  Halagon  oral solution  0,5mg 1ml 980ml 1TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere